Mutant Prevention Concentration of Ciprofloxacin against Klebsiella pneumoniae Clinical Isolates: An Ideal Prognosticator in Treating Multidrug-Resistant Strains

BACKGROUND: Fluoroquinolone-resistant Klebsiella pneumoniae poses a therapeutic challenge when implicated in urinary tract infections, pyelonephritis, pneumonia, skin infections, osteomyelitis, and respiratory infections. The mutant prevention concentration (MPC) represents a concentration threshold...

Descripción completa

Detalles Bibliográficos
Autores principales: Aditi Priyadarshini, B., Mahalakshmi, Krishnan, Naveen Kumar, Venkatesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855012/
https://www.ncbi.nlm.nih.gov/pubmed/31772582
http://dx.doi.org/10.1155/2019/6850108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855012/
https://www.ncbi.nlm.nih.gov/pubmed/31772582
http://dx.doi.org/10.1155/2019/6850108

Ejemplares similares